Stephen Krieger: Determining Best Treatments in Multiple Sclerosis

While having a number of choices to pick from when treating patients with multiple sclerosis can be advantageous there can also be challenges that need to be addressed by both doctors and patients

While having a number of choices to pick from when treating patients with multiple sclerosis can be advantageous there can also be challenges that need to be addressed by both doctors and patients

Speaking at the annual meeting of the American Academy of Neurology in Vancouver, Stephen Krieger, MD, Mount Sinai Hospital, said there is emerging data that could show a reverse of some of the damages of MS. Learning about clinical trials, and being there with a patient who is treated for the first time, Krieger said, is meaningful. “We could try things and be in studies that will benefit the patient, but it also benefits science,” he said.

He said there is a lot of interest in MS. “There are certainly more of us now than years ago, and that gives patients more opportunities to have MS-familiar doctors.”

Kreiger added with the broad aspects of MS could mean broad choices in treatment strategies. “I think we are going to see combined treatments of MS,” Krieger said. "I think it is going to get more complicated and more personalized."